TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/24/23 06:15 | 2/23/23 | VYGR | Voyager Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Neurocrine Biosciences Inc | CA | T | P | 39,033 | 8.88 | 0 | 4,396 | 105 | 8,575 | D | |||||||||||||||
3/14/19 16:34 | 3/12/19 | VYGR | Voyager Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Neurocrine Biosciences Inc | CA | T | P | 50,000 | 11.96 | 0 | 4,180 | New | 4,180 | D | |||||||||||||||
4/9/15 16:22 | 4/7/15 | NBIX | Neurocrine Biosciences Inc | CA | Health | BioPrd | Biological Products, (No Diag | Neurocrine Biosciences Inc | CA | D | M.d | 71 | 4.76 | 33 | 15 | 999% | 16 | 1 | 4 | -6 | 14 | -7 | 9 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |